https://www.selleckchem.com/pr....oducts/CGS-21680-hyd
On multivariate analysis, cytogenetic risk and D14 blasts less then 5% were predictive of CR/CR with incomplete count recovery (P less then .001). Cytogenetic risk (P less then .001), age less then 60 years (P = .001), and D14 blasts less then 5% (P = .045) predicted for OS. 2CI was performed in 131 patients (27%). Patients with hypocellular D14 BM but residual blasts (n = 106) underwent 2CI in 46% of cases, with improved remission rates (43.9% vs. 72.0%; P = .004) but no difference in OS. CONCLUSIONS The results from D1